Literature DB >> 21423002

National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007.

Jennifer A Frontera1, Natalia Egorova, Alan J Moskowitz.   

Abstract

OBJECTIVES: Subdural hematoma is a common type of intracranial hemorrhage, particularly among the elderly, yet, despite the aging U.S. population, little has been published in the last 10 yrs. This study aimed to determine national trends in prevalence, discharge disposition, length of stay, and cost of subdural hematoma over time.
DESIGN: Retrospective cohort study.
SETTING: Adult patients hospitalized in the United States between 1998 and 2007 identified in the Nationwide Inpatient Sample. PARTICIPANTS: Seven hundred twenty thousand, two hundred ninety-seven adult patients hospitalized in subdural hematoma.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Discharge disposition, hospital length of stay, and national cost (adjusted to 2007 dollars) were examined. Hospitalizations for subdural hematoma increased from 59,373 (30 per 100,000 hospitalizations) in 1998 to 91,935 (42 per 100,000) in 2007, constituting a 39% per-capita increase. The prevalence of subdural hematoma increased with age (p < .001), particularly among those >80 yrs of age (36% of subdural hematoma cohort), in lower income patients, in patients with acquired abnormalities of the coagulation cascade, and in patients with trauma. Inhospital mortality decreased from 15% to 12% (p = .001), but unsatisfactory discharge disposition increased from 17% to 20% (p < .001). National cost increased from $1.0 to $1.6 billion (p < .001). Unsatisfactory discharge disposition and cost were both independently predicted by higher comorbidity index, alcohol abuse, history of trauma, and acquired abnormal coagulation or platelet factors (p < .05). Neurosurgical intervention for subdural hematoma decreased from 41% in 1998 to 31% in 2007 (p < .001). Subdural hematoma evacuation was associated with decreased mortality but did not significantly protect against poor discharge disposition and was associated with significantly higher cost.
CONCLUSIONS: The prevalence and total cost for subdural hematoma has increased significantly in the last decade nationwide. Health resource consumption for subdural hematoma is increasing without clear evidence that management practices are leading to improved outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21423002     DOI: 10.1097/CCM.0b013e3182186ed6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Surgical Management of Chronic Subdural Hematoma in Older Adults: A Systematic Review.

Authors:  Nathan A Shlobin; Jayanidhi Kedda; Danielle Wishart; Roxanna M Garcia; Gail Rosseau
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-07-13       Impact factor: 6.053

2.  Predictors of Functional Outcome After Subdural Hematoma: A Prospective Study.

Authors:  Jonathan M Weimer; Errol Gordon; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

3.  Adverse Outcomes After Initial Non-surgical Management of Subdural Hematoma: A Population-Based Study.

Authors:  Nicholas A Morris; Alexander E Merkler; Whitney E Parker; Jan Claassen; E Sander Connolly; Kevin N Sheth; Hooman Kamel
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

4.  Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.

Authors:  Santosh B Murthy; Xian Wu; Ivan Diaz; Melvin Parasram; Neal S Parikh; Costantino Iadecola; Alexander E Merkler; Guido J Falcone; Stacy Brown; Alessandro Biffi; Judy Ch'ang; Jared Knopman; Philip E Stieg; Babak B Navi; Kevin N Sheth; Hooman Kamel
Journal:  Stroke       Date:  2020-03-17       Impact factor: 7.914

Review 5.  Non-electrographic Seizures Due to Subdural Hematoma: A Case Series and Review of the Literature.

Authors:  Joseph Driver; Aislyn C DiRisio; Heidi Mitchell; Zachary D Threlkeld; William B Gormley
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

6.  Antithrombotic regimens and need for critical care interventions among patients with subdural hematomas.

Authors:  David Robinson; Logan Pyle; Brandon Foreman; Laura B Ngwenya; Opeolu Adeoye; Daniel Woo; Natalie Kreitzer
Journal:  Am J Emerg Med       Date:  2021-03-13       Impact factor: 4.093

7.  Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of age.

Authors:  Patrick Mulligan; Bethwel Raore; Shuling Liu; Jeffrey J Olson
Journal:  J Neurosci Rural Pract       Date:  2013-07

8.  The "Young men may die, but old men must die" concept reappraised: The case of subdural hematomas.

Authors:  Georgios K Matis; Olga I Chrysou; Theodossios A Birbilis
Journal:  J Neurosci Rural Pract       Date:  2013-07

9.  Diffusion-Weighted Imaging Reveals Distinct Patterns of Cytotoxic Edema in Patients with Subdural Hematomas.

Authors:  David Robinson; Natalie Kreitzer; Laura B Ngwenya; Opeolu Adeoye; Daniel Woo; Jed Hartings; Brandon Foreman
Journal:  J Neurotrauma       Date:  2021-07-20       Impact factor: 4.869

10.  The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States.

Authors:  Ali Seifi; Ali Akbar Asadi-Pooya; Kevin Carr; Mitchell Maltenfort; Mehrdad Emami; Rodney Bell; Michael Moussouttas; Moussa Yazbeck; Fred Rincon
Journal:  Springerplus       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.